Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.

Here's Why You Should Invest in Intuitive Surgical (ISRG) Now

Conagra Brands

Take-Two Interactive Software

The following research was contributed by Christine Short, VP of Research at Wall Street Horizon. Executive Summary Shareholder meetings and conferences ramp up after a busy summer and ahead of the next earnings season The Delta variant forced many companies to quickly switch to webcasts and virtual meetings Macro issues such as regulatory risks and […] The post 3 Stocks To Watch As Shareholder Meeting Ramp Up Into Q3 Earnings appeared first on See It Market.

3 Stocks To Watch As Shareholder Meeting Ramp Up Into Q3 Earnings

Intuitive Surgical, Inc. (ISRG) Management Presents at Wells Fargo 2021 Virtual Healthcare Conference (Transcript)

Doing business as usual will be more than enough to make this company a strong investment.

This Robotics Growth Stock Could Turn $1,000 Into $4,000 by 2029

Salesforce

Pinterest

Block

Patience can pay off handsomely if you own stakes in dominant companies like these.

5 Winning Stocks That Can Make American Workers Rich by Retirement

Align Technology

DexCom

Their competition is in the rearview mirror, and customers are clamoring for their products.

3 Growth Stocks That'll Make You Richer By 2024

Intuitive Surgical, Inc. (ISRG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What Makes Intuitive Surgical, Inc. (ISRG) a New Strong Buy Stock

ABB Ltd.

AeroVironment

Global X Robotics & Artificial Intelligence ETF

iRobot

Oceaneering

Raytheon Technologies

Rising demand for robotics and AI technology across different industries has fueled significant growth in these robotics stocks. The post 7 Robotics Stocks to Buy for Elon Musk's Big ‘Tesla Bot' Bet  appeared first on InvestorPlace.

7 Robotics Stocks to Buy for Elon Musk's Big ‘Tesla Bot' Bet

Etsy

These stocks could yield attractive returns over the next 5 to 10 years.

Got $1,000? 3 Smart Stocks to Buy This Week

GoodRx Holdings

Given time, these companies might do a lot better than that.

3 Healthcare Stocks I Fully Expect to Double or More Within the Next 5 Years

3 Stocks Near Record Highs to Buy Now

SUNNYVALE, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Yong-Bum Choi as General Manager for South Korea, where he will direct business strategy and operations for the company.

Intuitive Appoints New General Manager in South Korea

Microsoft

Regeneron Pharmaceuticals

Look for the current all-time highs to be broken.

3 Growth Stocks Near Record Highs That Are Still Worth Buying

Is (ISRG) Outperforming Other Medical Stocks This Year?

Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?

Kroger

The S&P 500 showed strength to start the new week and hit a new peak on a vaccine boost. This benefited the KR, REGN, TJX, ISRG, MSFT stocks.

5 Stocks At the Forefront of the Latest S&P 500 Rally

Intuitive Surgical has just announced a 3-1 stock split to take place October 5th, 2021. The stock has had a terrific runup as investors realize this company is firing on all cylinders, generating gobs of cash, and the balance sheet is pristine.

Intuitive Surgical Upcoming Stock Split: What To Know

Duke Energy

Visa

History can be both the market's enemy and investors' friend.

Is a Stock Market Crash Coming? Here's What the Data Suggests

Investors are optimistic about Intuitive Surgical's (ISRG) strength in its da Vinci surgical system.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Behind It?

Intuitive Surgical, Inc. (ISRG) reported earnings 30 days ago. What's next for the stock?

Intuitive Surgical, Inc. (ISRG) Up 10% Since Last Earnings Report: Can It Continue?

Costco

Veeva Systems

When you find wonderful businesses, buy their stocks at attractive prices -- and hang on, for a long time.

3 Stocks I'll Hold Forever

There are great reasons to buy the stock -- but not because of its upcoming stock split.

Should You Buy Intuitive Surgical Ahead of Its Stock Split?

Innovative Industrial Properties

NVIDIA

All three should be able to move even higher.

3 Growth Stocks to Buy Near All-Time Highs

The stock price of Intuitive Surgical has seen a rise of over 8% over the last twenty-one trading days, and it is also up a solid 51% over the last twelve month period. The recent rise can be attributed to the announcement of a 3-to-1 stock split.

Will Intuitive Surgical Stock Continue To Make Fresh Highs?

Shopify

If these companies' historical performance is any indication, this goal seems achievable.

2 Unstoppable Stocks That Could Have a $1 Trillion Market Cap by 2040

Alphabet

And the legendary investor doesn't own any of them.

News for Intuitive Surgical Stock (ISRG)